COVID-19 vaccines and myocarditis.

Kerneis, Mathieu; Bihan, Kevin; Salem, Joe-Elie

Kerneis, Mathieu; Bihan, Kevin; Salem, Joe-Elie.

Kerneis M; Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Universitaire Pitié-Salpêtrière, AP-HP, 75013 Paris, France. Electronic address: mathieu.kerneis@aphp.fr.
Bihan K; Sorbonne Université, Clinical Investigations Center Paris-Est, Hôpital Universitaire Pitié-Salpêtrière, AP-HP, INSERM, 75013 Paris, France.
Salem JE; Sorbonne Université, Clinical Investigations Center Paris-Est, Hôpital Universitaire Pitié-Salpêtrière, AP-HP, INSERM, 75013 Paris, France.

Arch Cardiovasc Dis ; 114(6-7): 515-517, 2021.

Article in English | MEDLINE | ID: covidwho-1283842

Subject(s)

COVID-19 Vaccines/adverse effects; COVID-19/therapy; Myocarditis/chemically induced; SARS-CoV-2/immunology; Adult; COVID-19/epidemiology; Europe/epidemiology; Female; Humans; Incidence; Male; Middle Aged; Myocarditis/epidemiology; Young Adult

Keywords

COVID-19; Myocardite; Myocarditis; Pharmacovigilance; Vaccin; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Myocarditis Type of study: Observational study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Arch Cardiovasc Dis Journal subject: Vascular Diseases / Cardiology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google